Clinical trials: Malar Deficiency
Malar and Sub-malar Volume Deficiency
Efficacy and Tolerance Evaluation of a Bio-revitalizing Product Containing Hyaluronic Acid With High and Low Molecular Weight
Primary end point of the study was to evaluate clinically and by non-invasive instrumental evaluations tolerance and efficacy of a bio-revitalizing product containing hyaluronic acid with high (H-HA) and low (L-HA) molecular…
- Trial name
- NCT03270293
- Testing
- Profhilo
- Where
- Italy
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Derming SRL
Malar and Sub-malar Volume Deficiency
Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)
Aim of the study is to evaluate the re-volumizing performance and the duration effect of the product Aliaxin (new trademark) in women aged 40-65 years with midface volume defects due to aging mechanism.
- Trial name
- NCT03273660
- Testing
- Aliaxin (new trademark - IBSA Farmaceutici Italia S.r.l.)
- Where
- Italy
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Derming SRL